Scientists test 'Apoptosis Tracer' to spot hidden lung damage in smokers and COPD
NCT ID NCT02978144
Summary
This study tested a new radioactive imaging agent called Annexin to see if it could detect early lung cell damage in people with COPD and in healthy smokers. Researchers compared scans from 34 participants, including healthy non-smokers, healthy smokers, and people with moderate to severe COPD. The goal was to see if this method could help doctors diagnose COPD earlier and track its progression in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.